Cargando…
Insights from the molecular docking analysis of SGLT2 and FIMH to combat uropathogenicity
SGLT2 inhibitors are a novel class of FDA approved anti-diabetes drugs. They act by blocking the SGLT2 protein, which prevents glucose reabsorption, leading in enhance glucose excretion and lower blood glucose levels. In diabetic patients, SGLT2 inhibitors have been linked to urinary tract infection...
Autores principales: | Abdulaal, Wesam H, Bakhrebah, Muhammed A, Nassar, Majed S, Almazni, Ibrahim Abdullah, Almutairi, Wael Abdullah, Natto, Zuhair S, Khattab, Amin K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Biomedical Informatics
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484699/ https://www.ncbi.nlm.nih.gov/pubmed/37693079 http://dx.doi.org/10.6026/973206300181044 |
Ejemplares similares
-
Repurposing Anti-diabetic Drugs to Cripple Quorum Sensing in Pseudomonas aeruginosa
por: Hegazy, Wael A. H., et al.
Publicado: (2020) -
The short-term effect of different chlorhexidine forms versus povidone iodine mouth rinse in minimizing the oral SARS-CoV-2 viral load: An open label randomized controlled clinical trial study
por: Natto, Zuhair S., et al.
Publicado: (2022) -
Biocomputational Prediction Approach Targeting FimH by Natural SGLT2 Inhibitors: A Possible Way to Overcome the Uropathogenic Effect of SGLT2 Inhibitor Drugs
por: Mashraqi, Mutaib M., et al.
Publicado: (2021) -
FimH and Anti-Adhesive Therapeutics: A Disarming Strategy Against Uropathogens
por: Sarshar, Meysam, et al.
Publicado: (2020) -
Insightful Improvement in the Design of Potent Uropathogenic E. coli FimH Antagonists
por: Mousavifar, Leila, et al.
Publicado: (2023)